Keywords: phase, results, non-hodgkin, mabs, conventional, therapy, intermediate

PHASE I RESULTS WITH NON-HODGKIN'S MAbs

Article | 01 November 1993

Conventional therapy for intermediate and high-grade non-Hodgkin's lymphoma achieves an appreciable rate of remission, but has disappointing efficacy in those ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bristol-Myers Squibb

Go to company listing